BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37012457)

  • 1. Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma.
    Puram SV; Mints M; Pal A; Qi Z; Reeb A; Gelev K; Barrett TF; Gerndt S; Liu P; Parikh AS; Ramadan S; Law T; Mroz EA; Rocco JW; Adkins D; Thorstad WL; Gay HA; Ding L; Paniello RC; Pipkorn P; Jackson RS; Wang X; Mazul A; Chernock R; Zevallos JP; Silva-Fisher J; Tirosh I
    Nat Genet; 2023 Apr; 55(4):640-650. PubMed ID: 37012457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma.
    Zuo N; Ma L; Liu T; Hu W; Luo Y; Meng H; Ren Q; Deng Y; Wei L; Liu Q
    Oral Oncol; 2023 May; 140():106367. PubMed ID: 36996606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
    Sano D; Oridate N
    Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection.
    Cho YA; Chung JM; Ryu H; Kim EK; Cho BC; Yoon SO
    Cancer Res Treat; 2019 Jul; 51(3):1052-1063. PubMed ID: 30360033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
    Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
    Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma.
    Wang XI; Thomas J; Zhang S
    Ann Diagn Pathol; 2012 Jan; 16(1):7-12. PubMed ID: 22001331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
    Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
    Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Schrank TP; Lenze N; Landess LP; Hoyle A; Parker J; Lal A; Sheth S; Chera BS; Patel SN; Hackman TG; Major MB; Issaeva N; Yarbrough WG
    Cancer; 2021 Aug; 127(15):2788-2800. PubMed ID: 33819343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma.
    Mainguené J; Vacher S; Kamal M; Hamza A; Masliah-Planchon J; Baulande S; Ibadioune S; Borcoman E; Cacheux W; Calugaru V; Courtois L; Crozes C; Deloger M; Girard E; Delord JP; Dubray-Vautrin A; Larbi Chérif L; Dupain C; Jeannot E; Klijanienko J; Lameiras S; Lecerf C; Modesto A; Nicolas A; Rouzier R; Saada-Bouzid E; Saintigny P; Sudaka A; Servant N; Le Tourneau C; Bièche I
    Mol Oncol; 2022 Aug; 16(16):3001-3016. PubMed ID: 35398964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-Pk
    Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
    Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus, oropharyngeal cancer, and the latest vaccine: considerations for oral healthcare providers.
    Watt M; Li E; Closmann J; Chang O
    Gen Dent; 2024; 72(3):74-77. PubMed ID: 38640011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of human papillomavirus infection in head and neck cancers.
    Syrjänen S
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii243-5. PubMed ID: 20943622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients.
    Eggersmann TK; Baumeister P; Kumbrink J; Mayr D; Schmoeckel E; Thaler CJ; Dannecker C; Jeschke U; Nagler T; Mahner S; Sharaf K; Gallwas JKS
    Anticancer Res; 2020 Apr; 40(4):2117-2123. PubMed ID: 32234904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
    Lindsay CD; Kostiuk MA; Harris J; O'Connell DA; Seikaly H; Biron VL
    Clin Epigenetics; 2017; 9():95. PubMed ID: 28878842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INHBA is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer Progression.
    Abou Kors T; Hofmann L; Betzler A; Payer K; Bens M; Truong J; von Witzleben A; Thomas J; Kraus JM; Kalaajieh R; Huber D; Ezić J; Benckendorff J; Greve J; Schuler PJ; Ottensmeier CH; Kestler HA; Hoffmann TK; Theodoraki MN; Brunner C; Laban S
    Cancer Res Commun; 2024 Feb; 4(2):571-587. PubMed ID: 38329386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.